Latest Press Releases

Health News Posted on Wednesday, May 8, 2024

Premium Press Releases »

Philips Shareholders Approve all Proposals at the AGM 2024

May 7, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2024, including: The re-appointment of ...

Read More

Inteleos to Host Roundtable on Advancing Maternal Health through Point-Of-Care-Ultrasound Certification

ROCKVILLE, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification organization, will host a roundtable discussion titled "Advancing Maternal and Fetal Health through POCUS Training and Certification" on May ...

Read More

Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterinary Health Division. This enhancement is led by John Boshart, ...

Read More

Boehringer Ingelheim Shares Positive Results From the First Study Worldwide in Diabetic Macular Ischemia

Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic macular ischemia (DMI). The study found that BI 764524 was ...

Read More

Press Releases »

Naborforce Expands to Greensboro, Winston-Salem, High Point, and Wilmington to Support Older Adults and their Families as North Carolina's Aging Population Doubles

RICHMOND, Va. , May 8, 2024 /PRNewswire/ -- Naborforce, an age-tech company whose platform provides on-demand everyday assistance to seniors, today announced that it has expanded its nationally renowned services to Greensboro , ...

Read More

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

In a landmark move for Indian healthcare, the introduction of Second Opinion Online Consultation for Children (SOCC) represents a major step forward in revolutionising the way parents seek expert advice for their children's well-being. Spearheaded ...

Read More

Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever Anti-CD20 Antibody Conjugated Allogenic Gamma Delta T Cell Therapy for Non-Hodgkins Lymphoma

First dosing dohort was completed with complete response and disease stabilization identified at three months at the lowest dose level in the Phase 1 study No ACE1831-related serious adverse events, including GvHD, neurotoxicity, high-grade ...

Read More

Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of Patients with Recurrent or Metastatic Solid Tumors in Late-breaking Oral Presentation at the 2024 ASCO Annual Meeting

SHANGHAI , May 8, 2024 /PRNewswire/ -- Minghui Pharmaceutical, Inc., a late-stage clinical biopharmaceutical company focused on autoimmune diseases and oncology, will feature Dr. Lin Shen from Beijing Cancer Hospital at the upcoming ASCO ...

Read More

Newly Published Data in JAMA Cardiology Demonstrates Favorable Long-term Effects of the Corvia Atrial Shunt in Heart Failure Patients

Two years of echocardiographic data affirm positive effects of atrial shunt therapy on heart structure and function TEWKSBURY, Mass. , May 7, 2024 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment ...

Read More

FDA Grants Orphan Drug Designation to 9MW2821

SHANGHAI , May 7, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its self-developed novel Nectin-4-targeting ADC (R&D code: 9MW2821) has been granted ...

Read More

AKC Canine Health Foundation Marks Canine Cancer Awareness Month with $3.6 Million Invested in Active Cancer Research

RALEIGH, N.C. , May 7, 2024 /PRNewswire/ -- The AKC Canine Health Foundation (CHF), a non-profit organization dedicated to advancing the health of all dogs, marks Canine Cancer Awareness Month in May to highlight the impact of its funded canine ...

Read More

Lykos Therapeutics Announces FDA Advisory Committee Meeting to Review Investigational MDMA-Assisted Therapy for PTSD

Meeting to be held on June 4, 2024 First FDA Advisory Committee meeting for potential new PTSD treatment in 25 years SAN JOSE, Calif. , May 6, 2024 /PRNewswire/ -- Lykos Therapeutics (formerly MAPS Public Benefit Corporation) ...

Read More

Sun Life steps up and pledges more than $1 million for youth mental health

Commitment supports at-risk and marginalized youth across Canada TORONTO , May 6, 2024 /CNW/ - Ahead of National Child and Youth Mental Health Day tomorrow, Sun Life is pleased to announce a $1,050,000 million commitment over three ...

Read More

Message from the Governor General on Mental Health Week

OTTAWA, ON , May 6, 2024 /CNW/ - Mental health issues can impact anyone, at any point in their lives, and can present in many different ways. In any given year, it can affect one in five Canadians, from all walks of life, all cultures, all ...

Read More

GIBF invests $10 Million in Nectin Therapeutics to Advance Novel Pipeline of First-in-Class Immunotherapies and Antibody Drug Conjugates

Proceeds from financing to support ongoing clinical development of lead program targeting PVR as well as IND-enabling activities for multiple ADC candidates TEL AVIV, Israel , May 6, 2024 /PRNewswire/ -- Guangzhou-Israel Biotechnology ...

Read More

BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024

- Presentation Today, Monday, May 6, 2024 in Atlanta , Georgia  - TEL AVIV, Israel , May 6, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies ...

Read More

THE BETA GROUP: Do Race Horses Have to be Killed for a Fractured Leg?

MENLO PARK, Calif. , May 3, 2024 /PRNewswire/ --  Saturday will be the running of the 150th consecutive Kentucky Derby. One year ago, 12 horses died just before and after, sparking outrage in the press: ...

Read More

Mental Health Awareness Month Highlights Connection Between Gambling Disorder and Mental Wellness

Nearly 1 in 5 Ohioans are at risk of a gambling disorder and its consequences. COLUMBUS, Ohio , May 3, 2024 /PRNewswire/ -- As the world acknowledges the importance of addressing mental health topics, new data from Ohio for ...

Read More

Allergy and Asthma Experts Prepare for Air Quality Awareness Week

Media Advisory for Air Quality Awareness Week During National Asthma and Allergy Awareness Month MILWAUKEE , May 3, 2024 /PRNewswire-PRWeb/ -- May 6 - 10 is Air Quality Awareness Week, and experts in the allergy/immunology field are ...

Read More

Bridging Healthcare Gaps: The Wonder Woman Collective Unveils a New Vision for Women's Health

Five leading women's health companies, Paloma Health, Neura Health, LEVY Health, Seven Starling and Origin, have joined forces to announce The Wonder Woman Collective. This strategic partnership addresses critical gaps in women's healthcare, ...

Read More

Mother Suffering with NCPH and Hypersplenism Successfully Delivers Baby At BirthRight by Rainbow Hospitals

Mother Suffering with NCPH and Hypersplenism Successfully Delivers Baby At BirthRight by Rainbow HospitalsHyderabad 3rd May 2024: BirthRight by Rainbow Hospitals Financial District and Star Hospitals in a collaborative effort have showcased their ...

Read More

Innosphere launches non-pharmaceutical ADHD clinical trial at top-tier research hospitals seeking pediatric patients

Evaluating safety and efficacy of Novostim 2 wearable device as key step towards future submission to FDA for marketing authorization  Patients can enroll at UTHealth in Houston Texas , and soon at Mayo Clinic in Minnesota , Boston ...

Read More

Recently Published Real-World Evidence Study Shows Effectiveness of Cell-Based Quadrivalent Influenza Vaccine Over Three Seasons

A real-world evidence (RWE) study recently published in Open Forum Infectious Diseases (OFID) examined three consecutive U.S. flu seasons in the United States . The study suggests that cell-based quadrivalent influenza vaccine (QIVc) may have ...

Read More

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference

STATEN ISLAND, N.Y. , May 2, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial ...

Read More

NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme

PORTSMOUTH, N.H. , April 30, 2024 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a leading diagnostic and therapeutic medical technology company, welcomed the inclusion of Optilume ® Urethral Drug-Coated Balloon (DCB) into ...

Read More

Foresee Pharmaceuticals Announces First Subject Dosed in its First-in-Human Clinical Trial of FP-020

TAIPEI , April 30, 2024 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia . The Phase 1 clinical trial is a ...

Read More

ReNew Health to Pay $7 Million to Settle First-of-its-Kind COVID-19 False Claims Act Case

Zimmerman Reed announces $7 million settlement for the U.S. and State of California in a first-of-its kind False Claims Act case involving a COVID-19 waiver program. MINNEAPOLIS, Minn. , April 29, 2024 /PRNewswire-PRWeb/ -- ...

Read More

UT Health San Antonio-led STRONG STAR Consortium secures $17 million in DOD research funding for brain injuries, PTSD and more

A national consortium based at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded $17 million by the U.S. Department of Defense for new research in traumatic brain injury and psychological ...

Read More

PANTHERx® Rare Partnering with X4 Pharmaceuticals Inc. for the Distribution of XOLREMDI™ (mavorixafor), the First FDA-Approved Therapy Indicated for Use in Patients with WHIM Syndrome

PITTSBURGH , April 29, 2024 /PRNewswire/ -- PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, today announced it was selected by X4 Pharmaceuticals, Inc. for the distribution of ...

Read More

Government of Canada Supports Roger Neilson Children's Hospice's Project: Enhancing Access to Pediatric Palliative Care

Up to $1 million to develop a resource hub to support health care professionals in providing palliative care to children and families. OTTAWA, ON , April 29, 2024 /CNW/ - Everyone in Canada deserve access to the care they need, when ...

Read More

Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee

More than 20 million people in the U.S. are living with peripheral artery disease (PAD) yet there have been limited treatment options The first-of-its-kind Esprit™ BTK Everolimus Eluting Resorbable Scaffold dissolves over time after it has ...

Read More

No Burps. Guaranteed. Arctic Blue Offers a Truly Non-Fishy Omega-3 Fish Oil

Pure Arctic Cod Oil at Low Oxidation Levels Neutralize That Infamous Fishy Flavor, Turning Arctic Blue's Oils Into a Palatable, Ultra-Nutritious Supplement for the Whole Family FORT LAUDERDALE, Fla. , April 29, 2024 /PRNewswire/ -- Fish ...

Read More

Cinesteam® Is a Deodorizing Support Tool for Palliative Care

Palliative Care Is a Comprehensive Approach to Long-Term Patient Care. Caregivers Can Use Cinesteam®'s Secondary Dressings to Improve Quality of Life in Palliative Care Settings. FORT LAUDERDALE, Fla. , April 29, 2024 /PRNewswire/ ...

Read More

PLT Health Solutions Granted Broad Ranging Cognitive Health Claims from Health Canada Based on Clinical Study Results

Nutricog ® Cognitive Performance Complex has been Clinically Demonstrated to Improve Memory, Increase Learning Rate and Capacity, Enhance Focus and Concentration and Improve Overall Brain Function MORRISTOWN, N.J. , April 29, 2024 ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.